Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

ClinicalTrials.gov ID: NCT00107796

Public ClinicalTrials.gov record NCT00107796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 2:28 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of PROVIGIL ® (Modafinil) Treatment (100, 200, and 400 mg/Day) in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objectives: The primary objectives of the study are to determine the effectiveness of PROVIGIL treatment, compared to placebo treatment, in children and adolescents with excessive sleepiness (ES) associated with narcolepsy, as assessed by: * mean sleep latency from the Multiple Sleep Latency Test (MSLT) (average of 4 naps performed at 0900, 1100, 1300, and 1500) at the last post-baseline observation (week 6 or early termination) * the Clinical Global Impression of Change (CGI-C) ratings for ES, at the last post-baseline observation (week 6 or early termination).

Study identification

NCT ID
NCT00107796
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
140 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 16 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Not listed
Completion
Sep 2005 (Type not available)
Last update posted
Aug 24, 2012

2004 – 2005

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
59
Facility City State ZIP Site status
Robert Doekel, Jr., M.D. Birmingham Alabama 35213 —
Chris M. Makris, M.D. Birmingham Alabama 35233 —
Barbara Harris, Ph.D. Phoenix Arizona 85050 —
Derek Loewy, Ph.D. Tucson Arizona 85712 —
Stuart Quan, M.D. Tucson Arizona 85724 —
Joseph McCarty, M.D. Fort Smith Arkansas 72913 —
John L. Carroll, M.D. Little Rock Arkansas 72202 —
Samuel Boellner, M.D. Little Rock Arkansas 72205 —
Julie Thompson-Dobkin, D.O. Huntington Beach California 92648 —
Mark Buchfuhrer, M.D. Long Beach California 90806 —
Yury Furman, M.D. Los Angeles California 90048 —
Stuart Menn, M.D. Palm Springs California 92262 —
Richard Shubin, M.D. Pasadena California 91105 —
Lawrence Sher, M.D. Rolling Hills Estates California 90274 —
Milton K. Erman, M.D. San Diego California 92121 —
Stephen Brooks, M.D. San Francisco California 94109 —
Paul Haberman, M.D. Santa Monica California 90404 —
Jed Black, M.D. Stanford California 94305 —
Amerigo Padilla, M.D. Miami Florida 33173 —
Martin A. Cohn, M.D. Naples Florida 34110 —
D. Alan Lankford, Ph.D. Atlanta Georgia 30342 —
Gary Montgomery, M.D. Atlanta Georgia 30342 —
Jerry Silverboard, M.D. Atlanta Georgia 30342 —
Charles Wells, Jr., M.D. Macon Georgia 31208 —
Stephen H. Sheldon, D.O., FAAP Chicago Illinois 60614 —
Michael Kohrman, M.D. Chicago Illinois 60637 —
Anna Ivanenko, M.D., Ph.D. Maywood Illinois 60153 —
Henry Lahmeyer, M.D. Northfield Illinois 60093 —
James Cook, M.D. Danville Indiana 46122 —
William Leeds, D.O. Topeka Kansas 66606 —
Karen Waters, M.D. Louisville Kentucky 40202 —
Margaret Ann Springer, M.D. Shreveport Louisiana 71103 —
Helene A. Emsellem, M.D. Chevy Chase Maryland 20815 —
Marc Raphaelson, M.D. Frederick Maryland 21702 —
Daniela Minecan, M.D. Ann Arbor Michigan 48109 —
George Zureikat, M.D. Flint Michigan 48503 —
John Harsh, Ph.D., DABSM Hattiesburg Mississippi 39401 —
Pradeep Sahota, M.D. Columbia Missouri 65212 —
William Torch, M.D., MS Reno Nevada 89502 —
Kathleen Ryan, M.D. Mount Laurel New Jersey 08054 —
Sushmita Mikkilineni, M.D. New Brunswick New Jersey 08903 —
Monroe Karetzky, M.D. Newark New Jersey 07112 —
Lee Brooks, M.D. Princeton New Jersey 08540 —
Marc Seelagy, M.D. Trenton New Jersey 08629 —
Gary Zammit, M.D. New York New York 10025 —
James Lee, M.D. Charlotte North Carolina 28226 —
Bruce Corser, M.D. Cincinnati Ohio 45219 —
Raouf Amin, MD Cincinnati Ohio 45229 —
Martin Scharf, Ph.D. Cincinnati Ohio 45246 —
Carol Rosen, M.D. Cleveland Ohio 44106 —
Markus H. Schmidt, M.D., Ph.D. Dublin Ohio 43017 —
Michael Neeb, Ph.D. Toledo Ohio 43608 —
William C. Orr, Ph.D. Oklahoma City Oklahoma 73112 —
Jorg Pahl, M.D. Oklahoma City Oklahoma 73118 —
Dainis Irbe, M.D. Eugene Oregon 97401 —
William Pistone, M.D. Allentown Pennsylvania 18104 —
Jeffery Gould, M.D. Bethlehem Pennsylvania 18015 —
Guillermo Borrero, M.D. Clairton Pennsylvania 15025 —
Lee Brooks, M.D. Philadelphia Pennsylvania 19104 —
Judith Owens, M.D., MPH Providence Rhode Island 02903 —
Richard Bogan, M.D., FCCP Columbia South Carolina 29201 —
Julie Jacques, D.O. Morristown Tennessee 37814 —
John Hudson, M.D. Austin Texas 78756 —
David Sperry, M.D. Dallas Texas 75230 —
Todd J. Swick, M.D. Houston Texas 77024 —
Jerry J. Tomasovic, M.D. San Antonio Texas 78258 —
James M. Ferguson, M.D. Salt Lake City Utah 84107 —
Ralph A. Pascualy, M.D. Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2012 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00107796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →